Key result
Let-7a and let-7b overexpression suppresses LOX-1, attenuating oxLDL-induced endothelial injury and apoptosis.
Answers are grounded in this paper and cite their sources.
Lectin-like low-density lipoprotein receptor 1 (LOX-1) is a receptor for oxidized low density lipoprotein (oxLDL) in endothelial cells. The activation of LOX-1 by oxLDL stimulates the apoptosis and dysfunction of endothelial cells, and contributes to atherogenesis. However, the regulatory factors for LOX-1 are still unclear. MicroRNAs are small, endogenous, non-coding RNAs that regulate gene expressions at a post-transcriptional level. The let-7 family is the second microRNA been discovered, which plays important roles in cardiovascular diseases. Let-7a and let-7b were predicted to target LOX-1 3'-UTR and be highly expressed in endothelial cells. The present study demonstrated that LOX-1 was a target of let-7a and let-7b. They inhibited the expression of LOX-1 by targeting the positions of 310-316 in LOX-1 3'-UTR. Over-expression of let-7a and let-7b inhibited the oxLDL-induced endothelial cell apoptosis, NO deficiency, ROS over-production, LOX-1 upregulation and endothelial nitric oxide synthase (eNOS) downregulation. Moreover, we found that oxLDL treatment induced p38MAPK phosphorylation, NF-κB nuclear translocation, IκB degradation and PKB dephosphorylation. Let-7a or let-7b over-expression attenuated these alterations significantly. The present study may provide a new insight into the protective properties of let-7a and let-7b in preventing the endothelial dysfunction associated with cardiovascular disease, such as atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Bao et al. (2014) studied Oxidized low-density lipoprotein-induced endothelial cell injury / endothelial dysfunction. Let-7a and let-7b overexpression vs. oxLDL treatment without let-7a/let-7b overexpression was evaluated on LOX-1 expression and oxLDL-induced endothelial cell apoptosis, NO deficiency, ROS over-production, and eNOS downregulation. Let-7a and let-7b overexpression inhibited LOX-1 expression by targeting positions 310-316 in the LOX-1 3'-UTR and attenuated oxLDL-induced endothelial cell apoptosis and dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: